Amedisys Inc. (AMED) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Amedisys Inc. (AMED)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

92.00

0.03 (0.03%)

At close: Jan 14, 2025, 3:59 PM

91.98

-0.02%

After-hours Jan 14, 2025, 04:00 PM EST

undefined% (undefined)

Bid	91
Market Cap	3.01B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	2.52
PE Ratio (ttm)	36.51
Forward PE	n/a
Analyst	Hold

Ask	92.77
Volume	320,912
Avg. Volume (20D)	583,504
Open	92.00
Previous Close	91.97
Day's Range	91.65 - 92.10
52-Week Range	82.15 - 98.95
Beta	undefined

About AMED

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitatio...

[Show more]

Industry Medical - Care Facilities

Sector Healthcare

IPO Date Aug 17, 1994

Employees 19,000

Stock Exchange NASDAQ

Ticker Symbol AMED

Website https://www.amedisys.com

Analyst Forecast

According to 5 analyst ratings, the average rating for AMED stock is "Hold." The 12-month stock price forecast is $101, which is an increase of 9.78% from the latest price.

Buy 20.00%

Hold 80.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Amedisys Inc. is scheduled to release its earnings on Feb 19, 2025, during market hours.
Analysts project revenue of $596.53M, reflecting a 4.51% YoY growth and earnings per share of 1.07, making a 13.83% increase YoY.

Why Price Moved

2 weeks ago · Source

+4.67%

Amedisys shares are trading higher after the compa... Unlock content with Pro Subscription

News

5 days ago · zacks.com

UnitedHealth's $3.3B Merger Stalls as VitalCaring Sale Falls Through

UNH and AMED are now expected to identify new buyers for the divestment assets by March 2025.

2 weeks ago · zacks.com

Reasons to Retain AMED Stock in Your Portfolio Now

Amedisys' expected merger with UnitedHealth Group's Optum brings optimism to investors. Yet, a dull macroeconomic condition adds to the worry.

2 weeks ago · https://www.proactiveinvestors.com

Midnight Sun Mining secures Kazhiba target license renewal - ICYMI

Midnight Sun Mining Corp (TSX-V:MMA, OTCQB:MDNGF) director of marketing and communications Adrian O'Brien talked with Proactive about securing approval from Zambia's Mines Ministry for the renewal of ...

2 weeks ago · https://www.proactiveinvestors.com

Midnight Sun Mining: illuminating the Zambian-Congo copperbelt with pursuit of high-value deposits

UnitedHealth Group Inc (NYSE:UNH, ETR:UNH) and Amedisys (NASDAQ:AMED) have agreed to extend the deadline for their $3.3 billion merger, facing ongoing scrutiny from the US Department of Justice (DOJ)....

2 weeks ago · proactiveinvestors.com

UnitedHealth and Amedisys extend $3.3B merger deadline amid DOJ scrutiny

2 weeks ago · investopedia.com

Amedisys, UnitedHealth Group Extend Deadline To Complete $3.3B Merger

UnitedHealth Group (UNH) and Amedisys (AMED) agreed to extend the deadline to complete their $3.3 billion merger, after the U.S. Department of Justice moved to block it.

2 weeks ago · benzinga.com

Amedisys and UnitedHealth Extend Merger Deadline - What's Going On?

Amedisys Inc AMED shares are trading higher on Friday after the company announced it extended its merger deadline with UnitedHealth Group Incorporated UNH.

2 months ago · zacks.com

DOJ Lawsuit Questions UnitedHealth's $3.3 Billion Amedisys Deal

The DOJ suggests that UNH's acquisitions reflect a strategy of buying competitors rather than competing directly, potentially giving it control over multiple markets.

2 months ago · reuters.com

US sues to block UnitedHealth's $3.3 bln purchase of Amedisys

The Justice Department and three U.S. states filed a lawsuit on Tuesday to block UnitedHealth Group's $3.3 billion purchase of Amedisys Inc over concern the deal would harm competition in the market f...

2 months ago · reuters.com

US Justice Department preps suit over UnitedHealth-Amedisys deal, Bloomberg News reports

The U.S. Justice Department is moving to block UnitedHealth Group's $3.3 billion purchase of Amedisys Inc. over concerns the deal would harm competition in the market for home health services, Bloombe...

2 months ago · zacks.com

AMED Q3 Earnings and Revenues Miss, Margins Dip, Stock Falls

Amedisys, for the third quarter of 2024, delivers year-over-year top-line growth across three of its segments - Home Health, Hospice and High Acuity Care.

2 months ago · zacks.com

Amedisys (AMED) Reports Q3 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Amedisys (AMED) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall St...

2 months ago · zacks.com

Amedisys (AMED) Q3 Earnings and Revenues Lag Estimates

Amedisys (AMED) came out with quarterly earnings of $1 per share, missing the Zacks Consensus Estimate of $1.14 per share. This compares to earnings of $0.98 per share a year ago.

2 months ago · zacks.com

AMED or CHE: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Amedisys (AMED) and Chemed (CHE). But which of these two companies is the best op...

2 months ago · zacks.com

4 Stocks to Buy in an Evolving Outpatient Home Health Industry

Dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DGX, EHC, AMED and ADUS are well-poised ...

3 months ago · zacks.com

Will Amedisys (AMED) Beat Estimates Again in Its Next Earnings Report?

Amedisys (AMED) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

3 months ago · zacks.com

AMED vs. CHE: Which Stock Is the Better Value Option?

Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Amedisys (AMED) and Chemed (CHE). But which of these two stocks is more attractiv...